ArticleCureus2026
Markedly Discordant and Rapidly Changing Hemoglobin A1c Values in a Normoglycemic Patient: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemoglobin A1c (HbA1c) reflects average glycemia over approximately two to three months and is widely used for the diagnosis and monitoring of diabetes mellitus; however, discordant results may occur due to analytical interference, altered erythrocyte turnover, or preanalytical factors. We report a 31-year-old male with no known history of diabetes who presented for routine laboratory evaluation and was found to have an HbA1c of 13.9% despite a normal fasting plasma glucose of 89 mg/dL. Repeat testing of the same sample six hours later demonstrated a decrease to 7.5%, and a simultaneously collected new sample yielded an identical value. Over subsequent days, repeated measurements across multiple samples showed further decline and eventual stabilization at 5.8%. The patient remained asymptomatic, and additional evaluation did not support persistent hyperglycemia. Urine toxicology screening was positive for opioids, and the patient reported recent use of an unidentified substance. A follow-up sample obtained after two weeks confirmed a stable HbA1c of 5.8%. The rapid intra-sample variability and subsequent normalization observed in this case are inconsistent with the known kinetics of hemoglobin glycation and strongly suggest a non-physiological mechanism, most likely assay interference. This case emphasizes the importance of verifying unexpected HbA1c results prior to clinical decision-making to avoid misdiagnosis and inappropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.